Title:
【発明の名称】血管内皮増殖因子拮抗剤
Document Type and Number:
Japanese Patent JPH11502853
Kind Code:
A
Abstract:
The present invention provides human vascular endothelial cell growth factor (hVEGF) antagonists, including monoclonal antibodies, hVEGF receptors, and hVEGF variants that are useful for the treatment of age-related macular degeneration, as well as other diseases and disorders characterized by undesirable or excessive neovascularization.
Inventors:
Ferrara, napoleon
Kim, Kyun Ching
Kim, Kyun Ching
Application Number:
JP52968296A
Publication Date:
March 09, 1999
Filing Date:
March 28, 1996
Export Citation:
Assignee:
Genentech Incorporated
International Classes:
A61K45/00; A61K38/17; A61K38/18; A61K39/395; A61P27/02; C07K16/22; C07K16/28; A61K38/00; (IPC1-7): A61K45/00; A61K39/395
Attorney, Agent or Firm:
Masatake Shiga (1 person outside)